GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Marksans Pharma Ltd

Marksans Pharma: August 20 Fixed as Record Date for ₹0.90 Final Dividend

DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Jul 2026, 12:23 PM IST  ·  BSE ID: 43b82bb3-12f2-4820-9c55-6318846d8cfe
View Original BSE Filing (PDF)
💡
In Simple Terms
Marksans Pharma set August 20th as the date to decide who gets their recommended ₹0.90 dividend for last year.
🤖 AI Summary
  • August 20, 2026, set as record date for Marksans Pharma's final dividend.
  • Final dividend of ₹0.90 per equity share recommended for FY2026.
  • Shareholder approval needed at AGM scheduled for August 27, 2026.
  • Dividend payment expected on or after September 10, 2026, post-tax deduction.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Final Dividend per Equity Share
₹0.90
Face Value per Equity Share
₹1
Record Date for Dividend
20 August 2026
AGM Date
27 August 2026
Dividend Payment Date
On or after 10 September 2026
🏢 How This Affects the Company
💰
Financial Impact
This confirms the final dividend payout for FY2026, subject to shareholder approval, impacting distributable profits.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time. Shareholders should ensure their holdings are in demat form before August 20, 2026, to be eligible.
👤
Who Is Affected
Shareholders on the company's register as of August 20, 2026, will be eligible to receive the final dividend.
🔍
Management Signal
Management is proceeding with the planned dividend distribution, indicating confidence in financial performance for FY2026.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
AGM on August 27, 2026, for dividend approval.
Confirmation of dividend payment by September 10, 2026.
Annual Report for FY2026 release.
LOW RISK This is a standard corporate action related to dividend declaration and payment.
💡 Investor Takeaway
Marksans Pharma has fixed August 20, 2026, as the record date for its ₹0.90 per share final dividend for FY2026, pending member approval at the AGM on August 27, 2026.
⚖️ Strengths & Concerns

✅ Positives

  • Confirmation of ₹0.90 per share final dividend recommendation for FY2026.
📅 Company Track Record
Marksans Pharma had recommended a final dividend of ₹0.90 per share for FY2025-26, which was approved by the board.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the dividend per share declared by Marksans Pharma for FY2026?
Marksans Pharma declared a final dividend of ₹0.90 per equity share for the financial year ended March 31, 2026.
What is the record date for the Marksans Pharma dividend payment?
The record date for determining the eligibility of members to receive the final dividend is August 20, 2026.
When will the Marksans Pharma dividend be paid?
The final dividend, if approved at the AGM, will be paid on or after September 10, 2026.
When is the Marksans Pharma AGM scheduled for dividend approval?
The 34th Annual General Meeting of Marksans Pharma members, where the dividend approval will be sought, is scheduled for August 27, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.